Emcure Pharmaceuticals LimitedNSE: EMCURE

Press Release Mar 31 2025

· Issued by Emcure Pharmaceuticals Limited

Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 31, 2025, titled "Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI".

View Attachment

6ix hasn’t read this filing yet.

Emcure Pharmaceuticals Limited on 6ix

Earlier from Emcure Pharmaceuticals

Later from Emcure Pharmaceuticals

All Emcure Pharmaceuticals news releases